1. Home
  2. Our Team
  3. Research Postgraduate Students
  4. Miss Wanchun XU

Miss Wanchun XU

Wanchun Xu

PhD candidate, Department of Family medicine and Primary Care, The University of Hong Kong

Mphil in Health Policy, The School of Medicine and Health Management, Huazhong University of Science and Technology

Bachelor in Preventive Medicine, The School of Public Health, Sun Yat-sen University

 

Principle Supervisor: Dr. Eric Yuk Fai WAN

Co-supervisor: Professor Cindy L.K. LAM

email wanchunx@connect.hku.hk
Publications

Health service research in primary care

  1. Wanchun Xu, Yuan Wang, Peter Tanuseputro, Cindy Lo Kuen Lam, Eric Yuk Fai Wan*. Optimizing Physician Encounter Frequency for Type 2 Diabetes Patients in Primary Care Based on Cardiovascular Risk Assessment: A Target Trial Emulation Study. Diabetes, Obesity and Metabolism. 2024;26(11):5358-5367.
  2. Wanchun Xu, Ivy Lynn Mak, Ran Zhang, Esther Yee Tak Yu, Amy Pui Pui Ng, David Tak Wai Lui, David Vai Kiong Chao, Samuel Yeung Shan Wong, Cindy Lo Kuen Lam, Eric Yuk Fai Wan*. Optimizing the frequency of physician encounters in follow-up care for patients with type 2 diabetes mellitus: a systematic review. BMC Primary Care. 2024 Jan 26;25(1):41.
  3. Wanchun Xu†, Esther Yee Tak Yu†, Weng Yee Chin, Ivy Lynn Mak, Cheyenne I Ying Chan, Cindy Lo Kuen Lam*, Eric Yuk Fai Wan*. Team-based continuity of care for patients with hypertension: a retrospective cohort study in primary care. British Journal of General Practice. 2023.
  4. Wanchun Xu, Zijing Pan, Liang Zhang, Shan Lu*. Optimizing the medical equipment investment in primary care centres in rural China: evidence from a panel threshold model. BMC Health Services Research. 2024 Feb 1;24(1):160.

Pharmacoepidemiology research for cardiometabolic diseases

  1. Wanchun Xu, Yuk Kam Yau, Yanyu Pan, Emily Tsui Yee Tse, Cindy Lo Kuen Lam, Eric Yuk Fai Wan. Effectiveness and Safety of Using Statin for Primary Prevention of Cardiovascular Diseases in Hypercholesterolemic Elderly Patients with Chronic Kidney Diseases: A Target Trial Emulation Study. The Lancet Healthy Longevity. 2025. (in press)
  2. Wanchun Xu, Vincent KC Yan, Zhijuan Zhang, Kwun Kei Fung, Koon Ho Chan, Gary KK Lau, Celine SL Chui, Francisco TT Lai, Xue Li, Esther WY Chan, Ian CK Wong, Eric YF Wan. Myasthenia gravis following statin therapy: evidence from target trial emulation and self-controlled case series study. Nature Communications. 2024;15(1):10317.
  3. Franco Wing-Tak Cheng†, Wanchun Xu†, Sydney Chi-Wai Tang; Eric Yuk-Fai Wan. Long-Term Benefits and Safety of Statins in Patients with Kidney Failure: A Target Trial Emulation Study. Journal of the American Society of Nephrology, 2024;10.1681.
  4. Wanchun Xu, Lee Amanda Lauren, Cindy Lo Kuen Lam, Goodarz Danaei, Eric Yuk Fai Wan*. Benefits and Risks Associated with Statin Therapy for Primary Prevention in Old and Very Old Adults: Real-World Evidence from a Target Trial Emulation Study. Annals of Internal Medicine. 2024.
  5. Wanchun Xu†, Linda Chan†, Goodarz Danaei, Yuan Lu, Eric Yuk Fai Wan*. Long-term statin use and risk of cancers: a target trial emulation study. Journal of Clinical Epidemiology. 2024: 111425.
  6. Eric Yuk Fai Wan†*, Wanchun Xu†, Anna Hoi Ying Mok, Weng Yee Chin, Esther Yee Tak Yu, Celine Sze Ling Chui, Esther Wai Yin Chan, Ian Chi Kei Wong, Cindy Lo Kuen Lam, Goodarz Danaei*. Evaluating different low‐density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study. Diabetes, Obesity and Metabolism. 2024, 26(5): 1877-1887.